Background
Dr. Oshima is a hepatobiliary and gastrointestinal pathologist and the director of the Johns Hopkins Liver Pathology Service.
Languages: English, Japanese
Pathology
Hepatobiliary; Pathology
Dr. Oshima is a hepatobiliary and gastrointestinal pathologist and the director of the Johns Hopkins Liver Pathology Service.
Her research focuses on the study of neoplastic and non-neoplastic processes of the hepatobiliary system. Her ongoing projects include:
Yoshizawa T, Hong SM, Jung D, Noe M, Keimen A, Wu P, Wirtz D, Hruban R, Wood L, Oshima K. Three dimensional analysis of extrahepatic cholangiocarcinoma and tumor budding. J Pathol. 2020 Aug; 251(4):400-410
Rowan DJ, Logunova V, Oshima K. Measured residual tumor cellularity correlates with survival in neoadjuvant treated pancreatic ductal adenocarcinomas. Ann Diagn Pathol. 2019 Feb; 38:93-98
Eskandari F, Rowan DJ, Hari P, Kapke J, Schneidewend R, E Hagen C, Oshima K. Liver biopsy findings in patients with hematopoietic cell transplantation. Hum Pathol. 2017 Aug; 66:136-143
Pant M, Oshima K. Cholesteryl Ester Storage Disease: An underdiagnosed cause of cirrhosis in adults. Ann Diagn Pathol. 2017 Dec; 31:66-70
Lee JW, Zhang Y, Yoshizawa T, Argani P, Wood LD, Oshima K. Cancerization of ducts in hilar cholangiocarcinoma. Virchows Arch. 2022 May 9
Membership committee
Educational Travel and Awards Committee
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.